A carregar...
Emerging combination therapies for metastatic colorectal cancer – impact of trifluridine/tipiracil
Patients with metastatic colorectal cancer (mCRC) are surviving longer now than ever before, but mortality rates are still high and more effective therapies are clearly needed. For patients with disease that is refractory to fluoropyrimidines, oxaliplatin, irinotecan, and biologic agents targeting t...
Na minha lista:
| Publicado no: | Cancer Manag Res |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5635852/ https://ncbi.nlm.nih.gov/pubmed/29056855 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S113320 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|